Patrick Borgen, MD, on the Future of Personalized Medicine in Breast Cancer Care

A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.

A mother whose daughter is seven years past breast cancer treatment shares how scan anxiety and waiting shape life after cancer for survivors and families.

A review of 29 studies in more than 22,000 women 65 and older with ER-positive breast cancer found no statistically significant survival difference between hormone therapy alone and surgery first, though surgery controlled the cancer in the breast better.

A 12-year breast cancer survivor with 16 tattoos, including radiation marks, weighs new research on tattoos and lymphoma risk and the questions it prompts.

Ohio State hematologist Dr. Kerry Rogers says chemotherapy and newer targeted drugs both work well, and the right choice depends on the patient.

Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.

Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.

Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.